ELISA Sample Diluent with RF and HAMA Blockers

Description

ELISA Sample Diluent with RF and HAMA Blockers

ELISA Sample Diluent with RF and HAMA Blockers is a biotechnology-grade reagent designed to minimize interference from rheumatoid factor (RF) and human anti-mouse antibodies (HAMA) in immunoassay workflows. Supplied as a 30 mL solution, this diluent enhances assay specificity and accuracy by neutralizing common sources of false-positive signals. It is ideal for use in clinical diagnostics, vaccine potency assays, and biomarker detection platforms where sample matrix effects can compromise data integrity.

Researchers and assay developers working in immunology, infectious disease, and therapeutic monitoring rely on specialized diluents to reduce background noise and improve signal-to-noise ratios. This buffer integrates seamlessly into ELISA protocols and supports consistent performance across diverse sample types, including serum and plasma. Filtered through 0.22 m membranes and prepared with ultrapure water, it ensures high purity and reproducibility. Stored at 28C, it is compatible with manual and automated workflows.

Key benefits:

• Blocks RF and HAMA interference for improved ELISA accuracy

• Supplied as a 30 mL ready-to-use solution

• Compatible with serum, plasma, and other biological matrices

• Filtered through 0.22 m membranes using ultrapure water

• Stored at 28C for long-term stability and reproducibility

Products are for in vitro research use only (RUO).

References

• Roselle C, Whitehouse D, Follmer T, Ansbro F, Bouaraphan S, Guan L, Wang SK, Shank-Retzlaff M, Verch T. Evaluation of a digital dispenser for direct curve dilutions in a vaccine potency assay J Immunol Methods. 2017 Mar;442:20-28.
• Cho HJ, Deregt D, Joo HS. An ELISA for porcine reproductive and respiratory syndrome: production of antigen of high quality Can J Vet Res. 1996 Apr;60(2):89-93.
• Zhang XL, Li CF, Liang WN, Shao Y, Zeng Y, Meng J, Kong QJ, Ang ZJ. [Double-antibody sandwich method versus indirect method of ELISA for detection of prostatic exosomal protein in the urine] Zhonghua Nan Ke Xue. 2020 Jun;26(6):518-521.
• Pujol ML, Cirimele V, Tritsch PJ, Villain M, Kintz P. Evaluation of the IDS One-Step ELISA kits for the detection of illicit drugs in hair Forensic Sci Int. 2007 Aug 6;170(2-3):189-92.
• Song L, Lachno DR, Hanlon D, Shepro A, Jeromin A, Gemani D, Talbot JA, Racke MM, Dage JL, Dean RA. A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid- 1-42 peptide in human plasma with utility for studies of Alzheimers disease therapeutics Alzheimers Res Ther. 2016 Dec 15;8(1):58.
• Ji R, Shen Y, Shi B, Li H, Tang W, Xia C, Lu K, Lamu D, Hong Y, Sun X, Liu J, Zhang L, Zhu C. An ELISA based on soluble egg antigens for the serodiagnosis of animal schistosomiasis turkestanica PLoS One. 2020 Jan 29;15(1):e0228184.
• Steffen MJ, Ebersole JL. Sequential ELISA for cytokine levels in limited volumes of biological fluids Biotechniques. 1996 Sep;21(3):504-9.
• Smith SA, Lawson CM, McMichael MA, Jung K, OBrien M, Achiel R. Evaluation of assays for quantification of DNA in canine plasma as an indirect marker of NETosis Vet Clin Pathol. 2017 Jun;46(2):278-286.
• Pfleger C, Schloot N, ter Veld F. Effect of serum content and diluent selection on assay sensitivity and signal intensity in multiplex bead-based immunoassays J Immunol Methods. 2008 Jan 1;329(1-2):214-8.